₹200.5
(Inclusive of all Taxes)
Get Free delivery (₹99) with



Composition :
Manufacturer/Marketer :
Consume Type :
Expires on or after :
Return Policy :
About Efnocar-CT 40/12.5 Tablet
Efnocar-CT 40/12.5 Tablet is used to treat hypertension (high blood pressure). Hypertension is a lifelong or chronic condition in which the force exerted by the blood against the artery walls becomes too high. This can lead to complications such as heart attack, irregular heartbeat, kidney damage, and eye problems.
Efnocar-CT 40/12.5 Tablet contains two active ingredients: chlorthalidone (a diuretic or water pill) and Efonidipine (a calcium channel blocker). Chlorthalidone removes excess water and salts from the body by increasing urination, thereby reducing blood pressure. Efonidipine prevents calcium from entering the blood vessel walls, relaxing the vessels and lowering blood pressure.
Efnocar-CT 40/12.5 Tablet should be taken as advised by your doctor. Your doctor will determine the dose and duration of the medication based on your health condition. Efnocar-CT 40/12.5 Tablet may cause common side effects such as headache, dizziness, sweating, oedema (swelling caused by excess fluid), loss of appetite, stomach discomfort, palpitations (racing or pounding heart), hot flushes (sudden feelings of warmth), and hypotension (decreased blood pressure). Most of these side effects usually resolve on their own over time without requiring medical attention. However, if these side effects persist or worsen, consult your doctor.
Before using Efnocar-CT 40/12.5 Tablet , inform your doctor if you are allergic to any of its components, penicillin, or sulphonamide antibiotics. Efnocar-CT 40/12.5 Tablet should be used with caution in elderly patients, starting with the lowest recommended dose, as they are at high risk of reduced kidney, liver, or heart function. Efnocar-CT 40/12.5 Tablet is not recommended for patients with certain medical conditions, such as severe liver failure, severe kidney failure (creatinine clearance <30 mL/min), anuria (no urine production), low blood pressure (less than 90 mm of Hg), severe electrolyte imbalances (including low levels of potassium, sodium, or magnesium in the blood), Addison's disease (a condition where the adrenal glands do not produce enough steroid hormones), and a history of uric acid kidney stones or gout. Efnocar-CT 40/12.5 Tablet should not be used by pregnant or breastfeeding women unless advised by a doctor. Efnocar-CT 40/12.5 Tablet is not recommended for children under 18 years old due to a lack of information for this age group.
Uses of Efnocar-CT 40/12.5 Tablet
Efnocar-CT 40/12.5 Tablet is used in the treatment of hypertension (high blood pressure). The detailed uses of Efnocar-CT 40/12.5 Tablet are as follows:

Have a query?
Directions for Use
Key Benefits
Efnocar-CT 40/12.5 Tablet helps relax blood vessels, allowing blood to flow more easily throughout your body. It also increases urine production, helping to remove excess water from the body. As a result, it lowers blood pressure and reduces the risk of strokes, heart attacks, and kidney issues over time. While you may not notice immediate effects, it plays a crucial role in maintaining your long-term health. Even if you start feeling better, it’s important to take it regularly to ensure its continued effectiveness.
How Efnocar-CT 40/12.5 Tablet Works
Storage
What if I have taken an overdose of Efnocar-CT 40/12.5 Tablet
Drug Warnings
Do not use Efnocar-CT 40/12.5 Tablet if you are allergic to any of its components, penicillin, or sulphonamide antibiotics. Please inform your doctor if you are taking any prescription and non-prescription medications, including vitamins and herbal supplements, before starting Efnocar-CT 40/12.5 Tablet to rule out any side effects and interactions. Efnocar-CT 40/12.5 Tablet should be used with caution in elderly patients, starting with the lowest recommended dose, as they are at high risk of reduced kidney, liver, or heart function. Efnocar-CT 40/12.5 Tablet is not recommended for patients with certain medical conditions, such as severe liver failure, severe kidney failure (creatinine clearance 30 mL/min), anuria (no urine production), low blood pressure (less than 90 mm of Hg), severe electrolyte imbalances (including low levels of potassium, sodium, or magnesium in the blood), Addison's disease (a condition where the adrenal glands do not produce enough steroid hormones), and a history of uric acid kidney stones or gout. Efnocar-CT 40/12.5 Tablet should not be used by pregnant or breastfeeding women unless advised by a doctor. Efnocar-CT 40/12.5 Tablet is not recommended for children under 18 years old due to a lack of information for this age group. Efnocar-CT 40/12.5 Tablet may cause dizziness, so avoid standing up too quickly from a sitting or lying position. Also, avoid driving or operating any machines until you are fully alert after taking Efnocar-CT 40/12.5 Tablet . Stay hydrated and avoid hot weather, as Efnocar-CT 40/12.5 Tablet increases the frequency of urination. Additionally, inform your doctor before taking Efnocar-CT 40/12.5 Tablet if you are on a low salt diet, have recently taken lithium or an anesthetic, or have certain medical conditions, such as diabetes mellitus (high blood sugar), hyperlipidemia (high cholesterol levels), glaucoma (increased eye pressure), hypertensive crisis (severe increase in blood pressure), recent heart attack, or liver or kidney problems.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
Alcohol consumption may worsen the side effects of Efnocar-CT 40/12.5 Tablet . Therefore, avoid excessive alcohol consumption while on treatment with this medicine.
Pregnancy
Unsafe
Efnocar-CT 40/12.5 Tablet should not be used by pregnant women or those suspected of being pregnant.
Breast Feeding
Caution
Efnocar-CT 40/12.5 Tablet should not be used in lactating women unless the benefits clearly outweigh the potential risks to the child. Mothers undergoing Efnocar-CT 40/12.5 Tablet treatment should refrain from breastfeeding.
Driving
Unsafe
Efnocar-CT 40/12.5 Tablet may cause dizziness and affect your mental focus. Therefore, avoid driving or operating machines after taking this medicine.
Liver
Caution
Efnocar-CT 40/12.5 Tablet should be used with caution in case of liver impairment. Inform your doctor if you have liver problems before taking Efnocar-CT 40/12.5 Tablet . It should not be used in severe liver conditions.
Kidney
Caution
Efnocar-CT 40/12.5 Tablet should be used with caution in patients with a history of kidney disease. Inform your doctor if you have kidney problems before taking Efnocar-CT 40/12.5 Tablet . Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.
Children
Caution
Efnocar-CT 40/12.5 Tablet should not be used in children under 12 years old unless prescribed by a doctor. Your doctor may decide the dose of this medication based on your child's age, body weight, and health condition.
Heart
Caution
Efnocar-CT 40/12.5 Tablet should be used with caution in patients with heart problems. Therefore, please consult your doctor before using Efnocar-CT 40/12.5 Tablet .
Geriatrics
Consult your doctor
Efnocar-CT 40/12.5 Tablet should be used under medical supervision in geriatric patients due to increased risk of side effects. Therefore, please consult your doctor before using Efnocar-CT 40/12.5 Tablet .
Efnocar-CT 40/12.5 Tablet is an anti-hypertensive medicine used to treat hypertension (high blood pressure).
Efnocar-CT 40/12.5 Tablet contains two active ingredients: Chlorthalidone (a diuretic or water pill) and Efonidipine (a calcium channel blocker). Chlorthalidone works by removing excess water and salts from the body by increasing urination, thereby reducing blood pressure. Efonidipine works by preventing calcium from entering the blood vessel walls, which relaxes the vessels and reduces blood pressure.
The common side effects of Efnocar-CT 40/12.5 Tablet include headache, dizziness, sweating, oedema (swelling caused by excess fluid), loss of appetite, stomach discomfort, palpitations (racing or pounding heart), hot flushes (sudden feelings of warmth), and hypotension (decreased blood pressure). Most of these side effects usually resolve on their own over time without requiring medical attention. However, if these side effects persist or worsen, consult your doctor.
You are recommended to use Efnocar-CT 40/12.5 Tablet for the dose and duration advised by your doctor. Do not stop taking Efnocar-CT 40/12.5 Tablet without consulting your doctor, as it may lead to a sudden rise in blood pressure and increase the risk of heart attack and stroke.
Efnocar-CT 40/12.5 Tablet may affect your blood sugar levels. It is recommended to discuss with your doctor before taking Efnocar-CT 40/12.5 Tablet to know the possible risks associated with this medicine.
If your blood pressure drops too low after taking Efnocar-CT 40/12.5 Tablet , call your doctor immediately. Your doctor may need to adjust your dose or switch you to a different medication to get your blood pressure back to a normal level. Regularly check your blood pressure, drink plenty of water to stay hydrated, and be careful when standing up to avoid dizziness.
You are not recommended take Efnocar-CT 40/12.5 Tablet if you have certain medical conditions, such as severe liver failure, severe kidney failure (creatinine clearance <30 mL/min), anuria (no urine production), low blood pressure (less than 90 mm of Hg), severe electrolyte imbalances (including low levels of potassium, sodium, or magnesium in the blood), Addison's disease (a condition where the adrenal glands do not produce enough steroid hormones), and have a history of uric acid kidney stones or gout.
Country of origin
Manufacturer/Marketer address